Walder Wyss advises CRISPR on USD 600 Million Share Sale Program

In January 2021, CRISPR Therapeutics announced subsequent sales under the Open Market Sale Agreement with Jefferies LLC, under which CRISPR may offer and sell, from time to time at its sole discretion through Jefferies (as its sales agent), common shares having an aggregate offering price of up to USD 600 million. The sales will be made by any method that is deemed an “at the market offering” (ATM) under the US Securities Act. Together with the ATM-Program launched in 2020, the total volume has reached almost USD 1 billion.

CRISPR is a gene editing company focused on developing transformative gene-based medicines for serious diseases using its proprietary CRISPR/Cas9 platform. CRISPR/Cas9 is a revolutionary gene editing technology that allows for precise, directed changes to genomic DNA. CRISPR is headquartered in Zug, Switzerland. CRISPR’s common shares are listed on the Nasdaq.

The team 

Walder Wyss has acted as Swiss counsel to CRISPR in connection with the transaction. The team is being led by Alex Nikitine (Partner, Corporate/M&A, Capital Markets – pictured) and further includes Rafael Zemp (Managing Associate, Corporate/M&A, Capital Markets), Christian Lütolf (Associate, Corporate/M&A), Maurus Winzap (Partner, Tax) and Janine Corti (Counsel, Tax).

Walder Wyss advises CRISPR on USD 600 Million Share Sale Program

FabioAdmin

Legalcommunity.ch

Launched in 2020 by LC Publishing Group, it is the first digital portal addressed to the Swiss legal market.
In terms of contents, the website focuses on both law firms and in-house legal departments, covering the latest news and rumors on deals and operations (and the related advisors) as well as on lateral hires, moves and new appointments and providing insights, analytical data and opinions on the professions’ main trends and topics (Ai, innovation, etc.).

For further information, please visit the Group’s website www.lcpublishinggroup.com

LC Publishing Group S.p.A. – Via Tolstoi 10 – 20146 Milano – Tel. 0236727659 – C.F./P.IVA 07619210961
REA 1971432 Registro delle Imprese di Milano – Cap. Soc. Euro 50.000,00 i.v.

Copyright 2022 © All rights Reserved. Design by Origami Creative Studio

SHARE

Share on linkedin
Share on twitter
Share on facebook
Share on whatsapp
Share on email
Share on telegram